Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 409

1.

Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.

Fong JY, Pignata L, Goy PA, Kawabata KC, Lee SC, Koh CM, Musiani D, Massignani E, Kotini AG, Penson A, Wun CM, Shen Y, Schwarz M, Low DH, Rialdi A, Ki M, Wollmann H, Mzoughi S, Gay F, Thompson C, Hart T, Barbash O, Luciani GM, Szewczyk MM, Wouters BJ, Delwel R, Papapetrou EP, Barsyte-Lovejoy D, Arrowsmith CH, Minden MD, Jin J, Melnick A, Bonaldi T, Abdel-Wahab O, Guccione E.

Cancer Cell. 2019 Aug 12;36(2):194-209.e9. doi: 10.1016/j.ccell.2019.07.003.

PMID:
31408619
2.

Insecticide-Treated Mosquito Nets.

Carnevale P, Gay F.

Methods Mol Biol. 2019;2013:221-232. doi: 10.1007/978-1-4939-9550-9_16.

PMID:
31267505
3.

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs.

Montefusco V, Gay F, Spada S, De Paoli L, Di Raimondo F, Ribolla R, Musolino C, Patriarca F, Musto P, Galieni P, Ballanti S, Nozzoli C, Cascavilla N, Ben-Yehuda D, Nagler A, Hajek R, Offidani M, Liberati AM, Sonneveld P, Cavo M, Corradini P, Boccadoro M.

Haematologica. 2019 Jun 20. pii: haematol.2019.219139. doi: 10.3324/haematol.2019.219139. [Epub ahead of print]

4.

On the true identity of Sergentomyia gemmea and description of a closely related species: Se. raynali n. sp.

Depaquit J, Vongphayloth K, Siriyasatien P, Polseela R, Phumee A, Loyer M, Vol A, Varlot G, Rahola N, Brey PT, Sutherland IW, Hertz JC, Gay F, Léger N.

Med Vet Entomol. 2019 Jun 3. doi: 10.1111/mve.12393. [Epub ahead of print]

PMID:
31155766
5.

Redefining the treatment paradigm for multiple myeloma.

Gay F, Mina R.

Lancet Oncol. 2019 Jun;20(6):743-744. doi: 10.1016/S1470-2045(19)30295-5. Epub 2019 May 13. No abstract available.

PMID:
31097404
6.

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy.

Bruno G, Bringhen S, Maffei I, Iannaccone A, Crea T, Ravera A, Astarita A, Vallelonga F, Salvini M, Gay F, Veglio F, Milan A.

Cancers (Basel). 2019 May 3;11(5). pii: E622. doi: 10.3390/cancers11050622.

7.

Epidemiologic Trends in Malaria Incidence Among Travelers Returning to Metropolitan France, 1996-2016.

Kendjo E, Houzé S, Mouri O, Taieb A, Gay F, Jauréguiberry S, Tantaoui I, Ndour PA, Buffet P, Piarroux M, Thellier M, Piarroux R; French Imported Malaria Study Group.

JAMA Netw Open. 2019 Apr 5;2(4):e191691. doi: 10.1001/jamanetworkopen.2019.1691.

8.

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study.

Plesner T, Arkenau HT, Gay F, Minnema MC, Boccadoro M, Moreau P, Cavenagh J, Perrot A, Laubach JP, Krejcik J, Ahmadi T, de Boer C, Chen D, Chiu C, Schecter JM, Richardson PG.

Br J Haematol. 2019 Aug;186(3):e35-e39. doi: 10.1111/bjh.15879. Epub 2019 Mar 31. No abstract available.

PMID:
30931524
9.

CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab.

Castella B, Mina R, Gay F.

Cytometry A. 2019 Apr;95(4):416-418. doi: 10.1002/cyto.a.23752. Epub 2019 Mar 25. No abstract available.

PMID:
30908843
10.

Sensitivity of the superconducting state in thin films.

Tamir I, Benyamini A, Telford EJ, Gorniaczyk F, Doron A, Levinson T, Wang D, Gay F, Sacépé B, Hone J, Watanabe K, Taniguchi T, Dean CR, Pasupathy AN, Shahar D.

Sci Adv. 2019 Mar 15;5(3):eaau3826. doi: 10.1126/sciadv.aau3826. eCollection 2019 Mar.

11.

Leishmaniasis.

Depaquit J, Gay F, Kaltenbach ML.

Lancet. 2019 Mar 2;393(10174):871-872. doi: 10.1016/S0140-6736(18)33077-0. No abstract available.

PMID:
30837139
12.

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.

Bringhen S, Milan A, D'Agostino M, Ferri C, Wäsch R, Gay F, Larocca A, Offidani M, Zweegman S, Terpos E, Goldschmidt H, Cavo M, Ludwig H, Driessen C, Auner HW, Caers J, Gramatzki M, Dimopoulos MA, Boccadoro M, Einsele H, Sonneveld P, Engelhardt M.

J Intern Med. 2019 Jul;286(1):63-74. doi: 10.1111/joim.12882. Epub 2019 Apr 8.

PMID:
30725503
13.

Do we need cytogenetics in the follow-up of multiple myeloma?

Gay F, Goldschmidt H.

Br J Haematol. 2019 May;185(3):399-401. doi: 10.1111/bjh.15781. Epub 2019 Feb 1. No abstract available.

PMID:
30706441
14.

Low-Magnetic-Field Regime of a Gate-Defined Constriction in High-Mobility Graphene.

Veyrat L, Jordan A, Zimmermann K, Gay F, Watanabe K, Taniguchi T, Sellier H, Sacépé B.

Nano Lett. 2019 Feb 13;19(2):635-642. doi: 10.1021/acs.nanolett.8b02584. Epub 2019 Jan 24.

PMID:
30654611
15.

Low-temperature anomaly in disordered superconductors near B c2 as a vortex-glass property.

Sacépé B, Seidemann J, Gay F, Davenport K, Rogachev A, Ovadia M, Michaeli K, Feigel'man MV.

Nat Phys. 2019 Jan;15(1):48-53. doi: 10.1038/s41567-018-0294-6. Epub 2018 Oct 8.

16.

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group.

Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10.

PMID:
30545780
17.

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma.

Oliva S, Troia R, D'Agostino M, Boccadoro M, Gay F.

Front Immunol. 2018 Nov 27;9:2749. doi: 10.3389/fimmu.2018.02749. eCollection 2018. Review.

18.

Special problems in the management of elderly patients with multiple myeloma.

Gay F, Larocca A.

Eur J Intern Med. 2018 Dec;58:64-69. doi: 10.1016/j.ejim.2018.05.027. Review.

PMID:
30527921
19.

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials.

D'Agostino M, De Paoli L, Conticello C, Offidani M, Ria R, Petrucci MT, Spada S, Marcatti M, Catalano L, Gilestro M, Guglielmelli T, Baldini L, Gamberi B, Rizzi R, De Sabbata G, Di Renzo N, Patriarca F, Pezzatti S, Siniscalchi A, Ribolla R, Palumbo A, Montefusco V, Nagler A, Boccadoro M, Gay F.

Crit Rev Oncol Hematol. 2018 Dec;132:9-16. doi: 10.1016/j.critrevonc.2018.09.008. Epub 2018 Sep 14. Review.

PMID:
30447931
20.

Changes in the gills of the European eel (Anguilla anguilla) after chronic exposure to environmental cocaine concentration.

Capaldo A, Gay F, Laforgia V.

Ecotoxicol Environ Saf. 2019 Mar;169:112-119. doi: 10.1016/j.ecoenv.2018.11.010. Epub 2018 Nov 13.

PMID:
30445241
21.

CD38 as an immunotherapeutic target in multiple myeloma.

Bonello F, D'Agostino M, Moscvin M, Cerrato C, Boccadoro M, Gay F.

Expert Opin Biol Ther. 2018 Dec;18(12):1209-1221. doi: 10.1080/14712598.2018.1544240. Epub 2018 Nov 13. Review.

PMID:
30394809
22.

Shade trees have higher impact on soil nutrient availability and food web in organic than conventional coffee agroforestry.

Sauvadet M, den Meersche KV, Allinne C, Gay F, de Melo Virginio Filho E, Chauvat M, Becquer T, Tixier P, Harmand JM.

Sci Total Environ. 2019 Feb 1;649:1065-1074. doi: 10.1016/j.scitotenv.2018.08.291. Epub 2018 Aug 25.

PMID:
30308878
23.

The Mechanical Ventilation-Respiratory Distress Observation Scale as a surrogate of self-reported dyspnoea in intubated patients.

Decavèle M, Gay F, Persichini R, Mayaux J, Morélot-Panzini C, Similowski T, Demoule A.

Eur Respir J. 2018 Oct 10;52(4). pii: 1800598. doi: 10.1183/13993003.00598-2018. Print 2018 Oct. No abstract available.

PMID:
30209199
24.

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.

Caers J, Garderet L, Kortüm KM, O'Dwyer ME, van de Donk NWCJ, Binder M, Dold SM, Gay F, Corre J, Beguin Y, Ludwig H, Larocca A, Driessen C, Dimopoulos MA, Boccadoro M, Gramatzki M, Zweegman S, Einsele H, Cavo M, Goldschmidt H, Sonneveld P, Delforge M, Auner HW, Terpos E, Engelhardt M.

Haematologica. 2018 Nov;103(11):1772-1784. doi: 10.3324/haematol.2018.189159. Epub 2018 Aug 31.

25.

Aspergillus PCR in Bronchoalveolar Lavage Fluid for the Diagnosis and Prognosis of Aspergillosis in Patients With Hematological and Non-hematological Conditions.

Imbert S, Meyer I, Palous M, Brossas JY, Uzunov M, Touafek F, Gay F, Trosini-Desert V, Fekkar A.

Front Microbiol. 2018 Aug 14;9:1877. doi: 10.3389/fmicb.2018.01877. eCollection 2018.

26.

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis.

Gay F, Jackson G, Rosiñol L, Holstein SA, Moreau P, Spada S, Davies F, Lahuerta JJ, Leleu X, Bringhen S, Evangelista A, Hulin C, Panzani U, Cairns DA, Di Raimondo F, Macro M, Liberati AM, Pawlyn C, Offidani M, Spencer A, Hájek R, Terpos E, Morgan GJ, Bladé J, Sonneveld P, San-Miguel J, McCarthy PL, Ludwig H, Boccadoro M, Mateos MV, Attal M.

JAMA Oncol. 2018 Oct 1;4(10):1389-1397. doi: 10.1001/jamaoncol.2018.2961.

27.

Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA).

Bringhen S, Milan A, Ferri C, Wäsch R, Gay F, Larocca A, Salvini M, Terpos E, Goldschmidt H, Cavo M, Petrucci MT, Ludwig H, Auner HW, Caers J, Gramatzki M, Boccadoro M, Einsele H, Sonneveld P, Engelhardt M; European Hematology Association, the European Myeloma Network and the Italian Society of Arterial Hypertension.

Haematologica. 2018 Sep;103(9):1422-1432. doi: 10.3324/haematol.2018.191288. Epub 2018 Jul 26. Review.

28.

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias.

Gavriatopoulou M, Musto P, Caers J, Merlini G, Kastritis E, van de Donk N, Gay F, Hegenbart U, Hajek R, Zweegman S, Bruno B, Straka C, Dimopoulos MA, Einsele H, Boccadoro M, Sonneveld P, Engelhardt M, Terpos E.

Leukemia. 2018 Sep;32(9):1883-1898. doi: 10.1038/s41375-018-0209-7. Epub 2018 Jul 23. Review.

29.

Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK.

Depaquit J, Kaltenbach ML, Gay F.

Emerg Infect Dis. 2018 Aug;24(8):1599-1600. doi: 10.3201/eid2408.172147. No abstract available.

30.

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN).

Larocca A, Dold SM, Zweegman S, Terpos E, Wäsch R, D'Agostino M, Scheubeck S, Goldschmidt H, Gay F, Cavo M, Ludwig H, Straka C, Bringhen S, Auner HW, Caers J, Gramatzki M, Offidani M, Dimopoulos MA, Einsele H, Boccadoro M, Sonneveld P, Engelhardt M.

Leukemia. 2018 Aug;32(8):1697-1712. doi: 10.1038/s41375-018-0142-9. Epub 2018 Apr 25. Review.

31.

Effects of environmental cocaine concentrations on the skeletal muscle of the European eel (Anguilla anguilla).

Capaldo A, Gay F, Lepretti M, Paolella G, Martucciello S, Lionetti L, Caputo I, Laforgia V.

Sci Total Environ. 2018 Nov 1;640-641:862-873. doi: 10.1016/j.scitotenv.2018.05.357. Epub 2018 Jun 5.

PMID:
29879672
32.

Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma.

D'Agostino M, Gazzera G, Cetani G, Bringhen S, Boccadoro M, Gay F.

Curr Med Chem. 2018 May 13. doi: 10.2174/0929867325666180514114806. [Epub ahead of print]

PMID:
29756564
33.

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos MA, San-Miguel JF, Terpos E, Zweegman S, Garderet L, Mateos MV, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk NWCJ, Waage A, Beksac M, Mellqvist UH, Engelhardt M, Caers J, Driessen C, Bladé J, Sonneveld P.

Leukemia. 2018 Jul;32(7):1542-1560. doi: 10.1038/s41375-018-0040-1. Epub 2018 May 2. Review.

34.

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis.

Cerrato C, Di Raimondo F, De Paoli L, Spada S, Patriarca F, Crippa C, Mina R, Guglielmelli T, Ben-Yehuda D, Oddolo D, Nozzoli C, Angelucci E, Cascavilla N, Rizzi R, Rocco S, Baldini L, Ponticelli E, Marcatti M, Cangialosi C, Caravita T, Benevolo G, Ria R, Nagler A, Musto P, Tacchetti P, Corradini P, Offidani M, Palumbo A, Petrucci MT, Boccadoro M, Gay F.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19.

PMID:
29675792
35.

Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy.

Iannaccone A, Bruno G, Ravera A, Gay F, Salvini M, Bringhen S, Sabia L, Avenatti E, Veglio F, Milan A.

High Blood Press Cardiovasc Prev. 2018 Jun;25(2):209-218. doi: 10.1007/s40292-018-0256-1. Epub 2018 Mar 26.

PMID:
29582365
36.

Radiofrequency Ablation of Liver Tumors: No Difference in the Ablation Zone Volume Between Cirrhotic and Healthy Liver.

Cassinotto C, Denys A, Gay F, Duran R, Hocquelet A, Piron L, Guiu B.

Cardiovasc Intervent Radiol. 2018 Jun;41(6):905-911. doi: 10.1007/s00270-018-1898-z. Epub 2018 Feb 26.

PMID:
29484466
37.

Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?

Leleu X, Gay F, Flament A, Allcott K, Delforge M.

Ann Hematol. 2018 Mar;97(3):387-400. doi: 10.1007/s00277-017-3191-7. Epub 2017 Dec 27. Review.

38.

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

Nanni C, Versari A, Chauvie S, Bertone E, Bianchi A, Rensi M, Bellò M, Gallamini A, Patriarca F, Gay F, Gamberi B, Ghedini P, Cavo M, Fanti S, Zamagni E.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21.

PMID:
29270787
39.

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.

Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos MA, San-Miguel JF, Terpos E, Zweegman S, Garderet L, Mateos MV, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk NWCJ, Waage A, Beksac M, Mellqvist UH, Engelhardt M, Caers J, Driessen C, Sonneveld P.

Leukemia. 2017 Dec 18. doi: 10.1038/leu.2017.353. [Epub ahead of print] Review.

PMID:
29251284
40.

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.

Gay F, Engelhardt M, Terpos E, Wäsch R, Giaccone L, Auner HW, Caers J, Gramatzki M, van de Donk N, Oliva S, Zamagni E, Garderet L, Straka C, Hajek R, Ludwig H, Einsele H, Dimopoulos M, Boccadoro M, Kröger N, Cavo M, Goldschmidt H, Bruno B, Sonneveld P.

Haematologica. 2018 Feb;103(2):197-211. doi: 10.3324/haematol.2017.174573. Epub 2017 Dec 7. Review.

41.

Autologous transplant for myeloma: when the old meets the new.

Gay F, Genuardi M, Boccadoro M.

Oncotarget. 2017 Oct 8;8(53):90618-90619. doi: 10.18632/oncotarget.21605. eCollection 2017 Oct 31. No abstract available.

42.

What Does the Sleeping Brain Say? Syntax and Semantics of Sleep Talking in Healthy Subjects and in Parasomnia Patients.

Arnulf I, Uguccioni G, Gay F, Baldayrou E, Golmard JL, Gayraud F, Devevey A.

Sleep. 2017 Nov 1;40(11). doi: 10.1093/sleep/zsx159.

PMID:
29029239
43.

Emerging drugs and combinations to treat multiple myeloma.

Larocca A, Mina R, Gay F, Bringhen S, Boccadoro M.

Oncotarget. 2017 Jul 15;8(36):60656-60672. doi: 10.18632/oncotarget.19269. eCollection 2017 Sep 1. Review.

44.

Observation scales to suspect dyspnea in non-communicative intensive care unit patients.

Demoule A, Persichini R, Decavèle M, Morelot-Panzini C, Gay F, Similowski T.

Intensive Care Med. 2018 Jan;44(1):118-120. doi: 10.1007/s00134-017-4934-6. Epub 2017 Sep 20. No abstract available.

PMID:
28932879
45.

Percutaneous endovascular biopsy of intravascular masses: efficacy and safety in establishing pre-therapy diagnosis.

Pomoni A, Sotiriadis C, Gay F, Jouannic AM, Qanadli SD.

Eur Radiol. 2018 Jan;28(1):301-307. doi: 10.1007/s00330-017-4983-9. Epub 2017 Aug 4.

PMID:
28779399
46.

Risk factors for peripheral nerve injuries following neuraxial labour analgesia: a nested case-control study.

Haller G, Pichon I, Gay FO, Savoldelli G.

Acta Anaesthesiol Scand. 2017 Oct;61(9):1203-1214. doi: 10.1111/aas.12951. Epub 2017 Aug 2.

PMID:
28766691
47.

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.

McCarthy PL, Holstein SA, Petrucci MT, Richardson PG, Hulin C, Tosi P, Bringhen S, Musto P, Anderson KC, Caillot D, Gay F, Moreau P, Marit G, Jung SH, Yu Z, Winograd B, Knight RD, Palumbo A, Attal M.

J Clin Oncol. 2017 Oct 10;35(29):3279-3289. doi: 10.1200/JCO.2017.72.6679. Epub 2017 Jul 25.

48.

Multiple myeloma.

Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC.

Nat Rev Dis Primers. 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46. Review.

PMID:
28726797
49.

Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors.

Gay F, D'Agostino M, Giaccone L, Genuardi M, Festuccia M, Boccadoro M, Bruno B.

Clin Lymphoma Myeloma Leuk. 2017 Aug;17(8):471-478. doi: 10.1016/j.clml.2017.06.014. Epub 2017 Jun 17. Review.

PMID:
28689001
50.

Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis.

Ndour PA, Larréché S, Mouri O, Argy N, Gay F, Roussel C, Jauréguiberry S, Perillaud C, Langui D, Biligui S, Chartrel N, Mérens A, Kendjo E, Ghose A, Hassan MMU, Hossain MA, Kingston HWF, Plewes K, Dondorp AM, Danis M, Houzé S, Bonnefoy S, Thellier M, Woodrow CJ, Buffet PA; French Artesunate Working Group.

Sci Transl Med. 2017 Jul 5;9(397). pii: eaaf9377. doi: 10.1126/scitranslmed.aaf9377.

PMID:
28679662

Supplemental Content

Support Center